GlassScriptPhysician profile
Qingyan Zhu
NPI 1962422022
$5,055.48
in general payments reported to CMS, 2019-2025
37 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,508 · 2020: $906 · 2021: $1,516 · 2022: $127.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biogen, INC. | $848.70 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $536.43 | 2019-2020 | |
| Supernus Pharmaceuticals, INC. | $450.86 | 2019-2021 | |
| Amneal Pharmaceuticals LLC | $332.57 | 2019-2022 | |
| Amgen INC. | $282.54 | 2019-2021 | |
| Upsher-Smith Laboratories LLC | $273.41 | 2019-2021 | |
| Genentech USA, INC. | $228.24 | 2019-2021 | |
| Biohaven Pharmaceuticals, INC. | $225.32 | 2021 | |
| Ucb, INC. | $219.25 | 2019-2022 | |
| Allergan, INC. | $140.51 | 2019-2021 | |
| Genzyme Corporation | $136.07 | 2019-2021 | |
| Jazz Pharmaceuticals INC. | $127.55 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $119.65 | 2019-2020 | |
| Emd Serono, INC. | $115.45 | 2020-2021 | |
| Avanir Pharmaceuticals, INC. | $109.83 | 2019-2021 |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $102.35 | 2019-2021 | |
| Harmony Biosciences LLC | $97.80 | 2020-2022 | |
| Lundbeck LLC | $80.21 | 2020-2022 | |
| Sk Life Science, INC. | $70.18 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $68.36 | 2019-2020 | |
| Zyla Life Sciences, INC. | $67.85 | 2019-2020 | |
| Livanova USA, INC. | $61.35 | 2019-2020 | |
| Abbvie INC. | $58.70 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $43.29 | 2020 | |
| Pfizer INC. | $42.97 | 2019 | |
| Mallinckrodt Enterprises LLC | $30.88 | 2019 | |
| Mdd US Operations, LLC | $26.86 | 2019 | |
| Celgene Corporation | $24.28 | 2021 | |
| Neurocrine Biosciences, INC. | $20.64 | 2021 | |
| Promius Pharma LLC | $19.84 | 2019 | |
| Janssen Pharmaceuticals, INC | $17.13 | 2021 | |
| Neurelis, INC. | $14.47 | 2021 | |
| Biodelivery Sciences International, INC. | $13.88 | 2019 | |
| Ge Healthcare | $12.64 | 2019 | |
| Eisai INC. | $12.12 | 2021 | |
| Merck Sharp & Dohme LLC | $12.00 | 2020 | |
| Kyowa Kirin, INC. | $11.30 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Qingyan Zhu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.